Calliditas Therapeutics AB (CALT)
38.77
-0.30
(-0.77%)
USD |
NASDAQ |
Jun 14, 16:00
38.77
0.00 (0.00%)
After-Hours: 20:00
Calliditas Therapeutics Gross Profit Margin (Quarterly): 95.26% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 95.26% |
December 31, 2023 | 95.06% |
September 30, 2023 | 94.94% |
June 30, 2023 | 94.72% |
March 31, 2023 | 95.28% |
Date | Value |
---|---|
December 31, 2022 | 98.16% |
September 30, 2022 | 98.34% |
June 30, 2022 | 96.28% |
March 31, 2022 | 98.77% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
94.72%
Minimum
Jun 2023
98.77%
Maximum
Mar 2022
96.31%
Average
95.28%
Median
Mar 2023
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -126.6% |
Return on Assets | -30.74% |
Return on Invested Capital | -44.59% |
Profit Margin (Quarterly) | -83.31% |
Operating Margin (Quarterly) | -68.98% |
Return on Net Operating Assets | -31.67% |